Study: Galal 2024, Journal of Clinical and Aesthetic Dermatology

Postpartum Telogen Effluvium Unmasking Additional Latent Hair Loss Disorders

Citation

Galal et al (2024). Journal of Clinical and Aesthetic Dermatology. PubMed id 38779373.

Open on PubMed

Cards that cite this study (2)

Each card gives its own wording for who was tested, how and what was found.

  • Hair shedding after pregnancy, illness or stress Tier D

    B 200 women with postpartum hair loss, Egypt (n=200)

    Clinical and dermoscopic evaluation.

    Only 9.5% had telogen effluvium alone; 56.0% also had androgenetic alopecia, 6.5% also had traction alopecia and 28.0% had all three. The authors say postpartum telogen effluvium may be associated with other hair loss disorders.

    As recorded in this card: Galal et al (2024), Journal of Clinical and Aesthetic Dermatology, [primary]

    Note: Egyptian clinic sample, not African American or British Black women.

  • Hair types 4a, 4b, 4c: what typing tells you Tier D

    B 200 women with postpartum hair loss, Egypt (n=200)

    Clinical and dermoscopic evaluation.

    Only 9.5% had telogen effluvium alone; 56.0% also had androgenetic alopecia, 6.5% also had traction alopecia and 28.0% had all three. The authors say postpartum telogen effluvium may be associated with other hair loss disorders.

    As recorded in this card: Galal et al (2024), Journal of Clinical and Aesthetic Dermatology, [primary]

    Note: Egyptian clinic sample, not African American or British Black women.

This is information, not medical advice. If you are worried, see a doctor or pharmacist. How we grade the evidence. All studies.